Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism (2024) Vol. 160, pp. 156004-156004
Closed Access | Times Cited: 18
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 8
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Xin Qiu, Shuang Shen, Nizhen Jiang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Multi-pathway targeted therapy of MASH-HCC using miR-22
Ying Hu, Tahereh Setayesh, Dongguang Wei, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Precision medicine and nucleotide-based therapeutics to treat MASH
Andrea Caddeo, Stefano Romeo
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 7
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 5
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism (2024), pp. 156080-156080
Open Access | Times Cited: 5
Primary hepatic carcinosarcoma: a case report with insights from retrospective analysis of clinical characteristics and prognostic factors
Zonglei Zhao, Tao Wang, Zhexuan Sun, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota
Peng Shang, Moran Meng, Ping Luo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 895-895
Open Access
A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease
Byeong Geun Song, Goeun Park, Myung Ji Goh, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Hanjun Mo, Pengfei Yue, Qiaoqi Li, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
Regional Difference of Liver Cancer in Japan: A Real-world Evidence Using the National Database of Health Insurance Claims
Masahito Nakano, Machiko Kawaguchi, Dan Nakano, et al.
Internal Medicine (2025)
Open Access
Regular exercise alleviates metabolic dysfunction-associated steatohepatitis through rescuing mitochondrial oxidative stress and dysfunction in liver
Baoxuan Lin, Tong Wu, Mohammad Nasb, et al.
Free Radical Biology and Medicine (2025)
Closed Access
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis
Chittampalli Yashaswini, Bruno Cogliati, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Jeffrey R. Idle
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2882-2882
Open Access
Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, et al.
(2025) Vol. 2
Open Access
The FBP1‐TP53‐NRF2 metabolic switch in metabolic dysfunction‐associated steatohepatitis‐hepatocellular carcinoma progression and senescence reversal
Yahui Zhu, Donglin Wei, Michael Karin, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Inflammation in MASLD Progression and Cancer
Yeon Soo Kim, Y. C. Park, Hyunsoo Rho, et al.
JHEP Reports (2025), pp. 101414-101414
Open Access
Lipid Metabolism and Immune Response in Hepatocellular Carcinoma: Interplay Driving Tumor Progression
Tiffany Ching-Yun Yu, Yu‐Man Tsui, Xin Zhang, et al.
(2025)
Open Access
Pomegranate‐Derived Exosome‐Like Nanovesicles Containing Ellagic Acid Alleviate Gut Leakage and Liver Injury in MASLD
Jisu Kim, Byoung‐Joon Song, Young‐Eun Cho
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
Dietary Determinants of Metabolic Syndrome: Focus on the Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Manish Verma, Madhulika Tripathi, Brijesh Kumar Singh
IntechOpen eBooks (2024)
Open Access | Times Cited: 4
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
K.F. Au, Ming‐Hua Zheng, Wei‐Jei Lee, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 818-830
Closed Access | Times Cited: 4
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC)
Yujie Pan, Yunkuo Li, Fan Hong-yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117089-117089
Open Access | Times Cited: 3
Liver Cancer Etiology: Old Issues and New Perspectives
Jianguo Chen, Yong-Hui Zhang, Jianhua Lu, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1452-1468
Closed Access | Times Cited: 3
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top